2024
Brief Report: Should a prior cancer history be reevaluated as an exclusion for clinical trial participation?
Ayoade O, Canavan M, Caturegli G, Boffa D. Brief Report: Should a prior cancer history be reevaluated as an exclusion for clinical trial participation? Lung Cancer 2024, 198: 108032. PMID: 39561624, DOI: 10.1016/j.lungcan.2024.108032.Peer-Reviewed Original ResearchNon-small cell lung cancerAssociated with superior survivalSuperior survivalStage III NSCLC patientsCancer historyIII NSCLC patientsReceipt of immunotherapyNational Cancer DatabaseRegimens of chemotherapyStage IV patientsAnalyze overall survivalCell lung cancerKaplan Meier analysisStage III andCox proportional hazards modelsProportional hazards modelInnovative treatment approachesInfluence patient outcomesNSCLC patientsIV patientsOverall survivalImmunotherapy trialsCancer DatabaseMeier analysisNon-small
2018
Undertreated pain: Trends over time for older adults with and without cancer.
Presley C, Kapo J, Wang S, Canavan M, Sheinfeld E, Feder S, Kent E, Davidoff A. Undertreated pain: Trends over time for older adults with and without cancer. Journal Of Clinical Oncology 2018, 36: 15-15. DOI: 10.1200/jco.2018.36.30_suppl.15.Peer-Reviewed Original ResearchSevere pain interferencePain interferenceOlder adultsPain managementPain-related activity limitationsModerate pain interferenceSupportive care needsUse of opioidsNon-opioid analgesicsMultivariable logistic regressionPrescription medication usePart D coverageQuality of lifeCalendar year trendsPart D low-income subsidyLow-income subsidyPart D prescriptionsModerate painMedication useSymptom managementCancer historyChronic conditionsActivity limitationsLocal anestheticsCancer status